OctaGenix® Limited is a privately-owned UK based company with its headquarters located in Waltham Abbey Essex. OctaGenix® Limited has expertise in the areas of; Oncology, Obesity, Infection Control, Viral Diseases, Medical Cannabis, Drug Delivery Systems, and Orphan Drugs.
We endeavour to enhance and prolong patients’ lives, not just a mere slogan. We genuinely have unparalleled passion and commitment to ensure that a choice of well-being is available for those who we serve.
Our strategy is to ensure the durability of healthcare system, enhancing the pharmacoeconomic performances.
Patients remains at the heart of our core values, vision and everything we do. We plan to enhance patient access to critically needed treatments.
First and foremost, we are passionate about patients and they remain at the heart of everything we do.
At OctaGenix® we realise that healthcare professionals need more than just a pharmaceutical product.
Key stages of the Sars-CoV-2 life cycle SARS-CoV-2 the causative agent of COVID-19 is a member of the highly diverse coronavirus family, named for the crown-like spikes present on their surface. Like other members of this virus family, SARS-CoV-2 is an enveloped, positive-sense, single- stranded RNA virus. There are several key stages in the SARS-CoV-2 …
COVID – 19 and Our Response Our organisation comprises some of the World’s top researchers and scientists, with some of the big drug discoveries and research attached to their names. In February 2020, we knew exactly what was coming and fully anticipated the range of impacts, hence we felt the onus to contribute in the …
Artemisinin and COVID-19 Study We estimated that a vaccine could well be freely available after March 2021, but we cannot wait for the virus to claim thousands’ more lives, therefore we are in the process of setting-up a clinical study with Artemisinin to save lives of the infected COVID-19 patients. Based on the anti-Inflammatory and …